Pelvic organ prolapse is a disorder in which one or more of the pelvic organs drop from their normal position. This may result to the bulging of the bladder, rectal, and uterine tissue into the vagina. Women who have multiple vaginal birth have the greatest risk of pelvic organ prolapse after menopausal stage. The risk factors associated with POP are pelvic floor, connective tissue disorder, and obesity.
However, it does not have harmful effects but it can affect your quality of life. The treatment recommended by the doctor to women with POP is usually the ones which do not involve surgery. But if the patient experience major discomfort or inconvenience, she is entitled to undergo surgery to relieve symptoms and improve the quality of life.
Surgery may be an option for treating a prolapse if it is felt that the possible benefits outweigh the risks.There is about one in 10 women who by the time reached 80 years old undergo surgery for prolapse. Prolapse organ or tissue can be restored by repairing the supporting tissue through surgery.
One of the main surgical treatments for pelvic organ prolapse involves improving support for the pelvic organs. This may involve stitching prolapsed organs back into place, as well as stitching existing tissue to make it stronger.
There are two ways in which the pelvic organ can be repaired: through the vagina or through incisions. It is usually carried out under general anaesthetic, so you will be asleep during the operation and will not feel any pain. This type of operation is usually recommended if you want to have children in the future.
POP is commonly treated with the use of an implant called transvaginal mesh. However, this surgical mesh may actually do more harm than good, according to the Food and Drug Administration (FDA). In the last three years, the agency said, it has received almost 3,000 reports of complications from transvaginal mesh that was inserted surgically to treat pelvic organ prolapse. These adverse effects have resulted to serious injuries that have caused great pain and suffering to thousands of women. Click here to learn the ordeals these victims had to go through and the actions they have taken for their mesh injuries.
With only a few days to go before the start of the final bellwether trial against C.R. Bard, Judge Goodwin of the US District Court for the Southern District of West Virginia has issued an order for the registration of all pending cases and unfiled claims involving C.R. Bard.
This order is intended to ensure that pretrial proceedings having to do with Bard lawsuits, which have been consolidated under a multidistrict litigation (MDL), are conducted in an efficient manner. Particularly affected by this court order are counsels who represent one or more plaintiffs in the Bard MDL.
This may be very critical especially if we consider that there are over 6,000 pending cases against said defendant as of the end of 2013. This number is foreseen to increase in the months ahead.
The last bellwether trial that will tackle the vaginal mesh lawsuit of Carolyn Jones against C.R. Bard has been set for January 10, 2014. The first bellwether case, which was heard in August last year, was decided in favor of the plaintiff after the jury found C.R. Bard liable for the injuries sustained by Donna Cisson. The second trial was cancelled after Bard opted for an out-of-court settlement.
Read More: Federal Judge Orders Census of Pending C.R. Bard Vaginal Mesh Lawsuits
Should the petition of a group of plaintiffs who had earlier filed vaginal mesh lawsuits in different federal courts in the country be approved, Neomedic Incorporated may become the seventh multidistrict litigation (MDL) in the US District Court for the Southern District of West Virginia under Judge Joseph Goodwin.
In their request before the Judicial Panel on Multidistrict Litigation (JPML) dated November 8, 2013, around two dozen plaintiffs asked for a consolidation in the West Virginia district court since according to them, Judge Goodwin handles the majority of related litigation that could be coordinated with the product actions involving other manufacturers. The establishment of an MDL is aimed at facilitating pre-trial procedures which can be very time-consuming.
In their claims against Neomedic, the plaintiffs alleged that they experienced severe complications such as mesh erosion, chronic infections, severe pain, and vaginal scarring after being implanted with the company’s Contasure and Remeex vaginal mesh devices supposedly to repair there pelvic organ prolapse (POP) and stress urinary incontinence.
If this petition is approved by the JPML, Neomedic Incorporated will join other MDLs which currently include Ethicon Inc., American Medical Systems, C.R. Bard, Boston Scientific, Coloplast, and Cook Medical.
Read More: Vaginal Mesh Victims Ask JPML to Create New MDL